Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. (Q45296414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marta Coscia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Barbara Castella

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Massimo Massaia

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Muraro M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pantaleoni F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Fiore F

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nuschak B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Peola S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Foglietta M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Palumbo A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Bruno B

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Bertieri R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Boano L

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Boccadoro M

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

664-670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Reactivity of gamma delta T cells induced by the tumour cell line RPMI 8226: functional heterogeneity of clonal populations and role of GroEL heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Distribution of T-cell signalling molecules in human myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Increased Natural Killer Cell Activity in Viremic HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403693

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15744346%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 January 2020

1011187955

0 references

1 reference